Stay updated on Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a significant update in the study evaluating the changes in visual function at 12 months following a single injection of human retinal progenitor cells in adults with Retinitis Pigmentosa. This change reflects a potential advancement or adjustment in the research findings related to the safety and efficacy of the treatment intervention.
    Difference
    0.1%
    Check dated 2024-06-06T14:47:01.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change includes examples of eligibility criteria such as a person's general health condition or prior treatments.
    Difference
    15%
    Check dated 2024-05-22T21:26:17.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:21:18.000Z thumbnail image

Stay in the know with updates to Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intravitreal Retinal Progenitor Cells in Retinitis Pigmentosa Clinical Trial page.